These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28939742)

  • 1. Integrated Analysis Reveals Tubal- and Ovarian-Originated Serous Ovarian Cancer and Predicts Differential Therapeutic Responses.
    Hao D; Li J; Jia S; Meng Y; Zhang C; Wang L; Di LJ
    Clin Cancer Res; 2017 Dec; 23(23):7400-7411. PubMed ID: 28939742
    [No Abstract]   [Full Text] [Related]  

  • 2. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
    Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG
    Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.
    Hu Z; Artibani M; Alsaadi A; Wietek N; Morotti M; Shi T; Zhong Z; Santana Gonzalez L; El-Sahhar S; Carrami EM; Mallett G; Feng Y; Masuda K; Zheng Y; Chong K; Damato S; Dhar S; Campo L; Garruto Campanile R; Soleymani Majd H; Rai V; Maldonado-Perez D; Jones S; Cerundolo V; Sauka-Spengler T; Yau C; Ahmed AA
    Cancer Cell; 2020 Feb; 37(2):226-242.e7. PubMed ID: 32049047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae.
    Auersperg N
    Int J Gynecol Pathol; 2013 Sep; 32(5):444-53. PubMed ID: 23896717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precursor lesions and prognostic factors in primary peritoneal serous carcinoma.
    Lee S; Nelson G; Duan Q; Magliocco AM; Duggan MA
    Int J Gynecol Pathol; 2013 Nov; 32(6):547-55. PubMed ID: 24071870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
    Klotz DM; Wimberger P
    Arch Gynecol Obstet; 2017 Dec; 296(6):1055-1062. PubMed ID: 28940023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens.
    Esselen KM; Ng SK; Hua Y; White M; Jimenez CA; Welch WR; Drapkin R; Berkowitz RS; Ng SW
    Gynecol Oncol; 2014 Feb; 132(2):316-21. PubMed ID: 24333360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
    Klinkebiel D; Zhang W; Akers SN; Odunsi K; Karpf AR
    Mol Cancer Res; 2016 Sep; 14(9):787-94. PubMed ID: 27259716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
    Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
    de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
    Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer.
    Lo Riso P; Villa CE; Gasparoni G; Vingiani A; Luongo R; Manfredi A; Jungmann A; Bertolotti A; Borgo F; Garbi A; Lupia M; Laise P; Das V; Pruneri G; Viale G; Colombo N; Manzo T; Nezi L; Cavallaro U; Cacchiarelli D; Walter J; Testa G
    Genome Med; 2020 Oct; 12(1):94. PubMed ID: 33121525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian cancer--modern approach to its origin and histogenesis].
    Nowak-Markwitz E; Spaczyński M
    Ginekol Pol; 2012 Jun; 83(6):454-7. PubMed ID: 22880466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.